Incyte to Report Fourth Quarter and Year-End 2023 Financial Results
- None.
- None.
The schedule for the press release and conference call/webcast is as follows:
- Q4 & YE 2023 Press Release: February 13, 2024 at 7:00 a.m. ET
- Q4 & YE 2023 Conference Call: February 13, 2024 at 8:00 a.m. ET
- Domestic Dial-In Number: 877-407-3042
- International Dial-In Number: 201-389-0864
- Conference ID Number: 13744020
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the
The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.
About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in
For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, Twitter, Instagram, Facebook, YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240123747153/en/
Incyte Contacts
Media
media@incyte.com
Investors
ir@incyte.com
Source: Incyte
FAQ
When is Incyte's Q4 & YE 2023 financial results conference call and webcast scheduled?
What time is the Q4 & YE 2023 press release?
How long will the replay of the conference call be available?